Abstract: Method for reducing the pollutant emissions of internal combustion engines, wherein an aqueous solution containing glyoxal and a polymer product of citric acid and glycerol is added as an additive, additive for reducing the pollutant emissions of internal combustion engines, said additive consisting of an aqueous solution containing glyoxal and a polymer product of citric acid and glycerol, and the use thereof for reducing pollutant emissions.

Abstract: The present invention relates to agents for intra-articular injection that contain a mixture of alpha-tocopherol, phospholipids or poloxamers or sodium oleate, proteoglycans, and a cortisone crystal suspension or a cortisone crystal solution. The agents are suitable for therapy of rheumatic diseases, in particular of arthrosis.

Abstract: The present invention relates to agents for intra-articular injection that contain a mixture of alpha-tocopherol, phospholipids or poloxamers, proteoglycans, and a cortisone crystal suspension or a cortisone crystal solution. The agents are suitable for therapy of rheumatic diseases, in particular of arthrosis.

Abstract: The present invention relates to a whole-blood culture containing specific immunocompetent killer cells that are activated against tumor cells, viruses, bacteria and/or allergens, whereby the whole-blood culture consists of whole-blood and a culture medium at a ratio of 3:1 to 4:1, whereby the culture medium has an oxygen excess of at least 100% or more and contains a water-soluble emulsification product comprising a mixture of phospholipids, vitamin E, and low-molecular proteoglycans with a molecular weight of 1,200 to 12,000 Dalton, and whereby dead tumor cells or fragments thereof and/or viral and/or bacterial antigens and/or allergens have been added to the whole-blood culture [to serve] as antigen in the specific recognition process for production of the activated killer cells (stimulation). The invention also relates to a method for producing the culture, as well as stimulants for the whole-blood culture and a method for the selection thereof.

Abstract: The present invention relates to agents for intra-articular injection that contain a mixture of alpha-tocopherol, phospholipids, proteoglycans, and a cortisone crystal suspension or a cortisone crystal solution. The agents are suitable for therapy of rheumatic diseases, in particular of arthrosis.

Abstract: The present invention relates to a whole-blood culture containing specific immunocompetent killer cells that are activated against tumor cells, viruses, bacteria and/or allergens, whereby the whole-blood culture consists of whole-blood and a culture medium at a ratio of 3:1 to 4:1, whereby the culture medium has an oxygen excess of at least 100% or more and contains a water-soluble emulsification product comprising a mixture of phospholipids, vitamin E, and low-molecular proteoglycans with a molecular weight of 1,200 to 12,000 Dalton, and whereby dead tumor cells or fragments thereof and/or viral and/or bacterial antigens and/or allergens have been added to the whole-blood culture [to serve] as antigen in the specific recognition process for production of the activated killer cells (stimulation). The invention also relates to a method for producing the culture, as well as stimulants for the whole-blood culture and a method for the selection thereof.

Abstract: Glyoxal in an aqueous solution is used in a fuel additive in order to reduce pollutants in the exhaust gases of gasoline and diesel engines. It is sufficient to add glyoxal in aqueous solution to gasoline in the dilution in the ratio of 1:10 000 and higher in order to obtain a reduction of unburned hydrocarbons and carbon monoxide in vehicles with catalytic converters at idle and at increased idle of almost 100%. Esterified aliphats and polyethyleneglycol are added as emulsifiers and solubilizers. Additionally, glyoxal can be used in form of its acetals and hemiacetals with the resultant product being added to the fuel in combustion engines in order to reduce the pollutant emission and carbon particles/deposits.

Abstract: A method for chemical modification of mammal urine and mammal blood is disclosed.

Abstract: The invention relates to a medicament containing mixtures of betasitosterol and phytosterol and/or betasitosterol and its physiological metabolites. Processes were discovered for dissolving betasitosterol, which in itself is difficult to dissolve, in various oils and paraffins and in glycerin, which processes offer new indications for the use of these substances. In addition, the esterification of the betasitosterol with carboxylic acids opens up therapeutic possibilities in asthma, inflammatory intestinal diseases, arterial hypertension, autoimmune diseases of the skin and pain relief which far exceed the currently known range of uses of betasitosterol and phytosterol/betasitosterol mixtures.

Abstract: A method for chemical modification of mammal urine and mammal blood is disclosed.

Abstract: The invention relates to a medicament containing mixtures of betasitosterol and phytosterol and/or betasitosterol and its physiological metabolites. Processes were discovered for dissolving betasitosterol, which in itself is difficult to dissolve, in various oils and paraffins and in glycerin, which processes offer new indications for the use of these substances. In addition, the esterification of the betasitosterol with carboxylic acids opens up therapeutic possibilities in asthma, inflammatory intestinal diseases, arterial hypertension, autoimmune diseases of the skin and pain relief which far exceed the currently known range of uses of betasitosterol and phytosterol/betasitosterol mixtures.

Abstract: A process is disclosed for the production of immune-genetically active suspensions of which the initial substances are fluids or tissues from the human or animal body. Autohemotherapy, immune-stimulatory and/or immune-suppressive effects are employed. The suspensions thus produced can be used as pooled sera as desired.

Abstract: A method for chemical modification of mammal urine and mammal blood is disclosed.

Abstract: The invention is a fuel and a method for producing an improved hydrocarbon fuel for internal combustion engines and turbines. The method includes the steps of subjecting a conventional hydrocarbon liquid fuel to ozonization. The ozonization is performed under one of two conditions. The first of the two conditions is a process of forming a current of the liquid fuel and bubbling an ozone-oxygen mixture in a countercurrent through the liquid fuel. The second of the two conditions is a process of enriching the liquid fuel with oxygen and subjecting the enriched fuel with ultraviolet radiation. Desirable concentrations of ozonization products in the fuel are from 0.1% o to 2.0% o.

Abstract: A sailing provision includes a multiprofile sail with a plurality of individual profiles, which overlap each other and which are variable in their distance from each other. The multiprofile sail replaces conventional one piece head sails or main sails. The multiprofile sails can be trimmed via a special rope construction and can be tensioned in windward or leeward direction. Since the individual profiles can be rotated rapidly around their axis near the luff of the sail, the system offers a capsizing security independent of tensioning in windward or lee direction and/or independent of the heeling angle.

Abstract: An acupuncture instrument for use in producing analgesia comprises a needle having a head and an electrical connection for applying a transformer arrangement including an electric coil constituting a secondary winding of the transformer arrangement and having two poles, one of the poles being insulated therefrom, the electric coil being arranged on the needle head and being capable of being surrounded by another coil constituting a primary winding of the transformer arrangement, and an annular electrode electrically connected to the other pole of the secondary winding and insulated with respect thereto and vertically movably arranged on the secondary winding.